Main Article Content
BACKGROUND: Laparoscopic cholecystectomy is now often an ambulatory procedure, but dependent on short-term post-operative complaints of pain and post-operative nausea and vomiting (PONV). The efficacy of analgesics is therefore important to facilitate return to normal functions. We investigated to know about the efficacy of analgesics and duration of analgesics required for the management of pain seen in post-operative Laparoscopic Cholecystectomy.
METHODOLOGY: A Prospective Observational study was conducted from January 2016 to June 2016 at Malla Reddy Hospital. 30 patients were admitted for Laparoscopic Cholecystectomy. All the necessary and relevant data were collected from the patient case notes, treatment charts, and laboratory reports. The questionnaires were filled by directly interviewing the patient. These data were recorded in a specially designed patient proforma/questionnaire’s. Cases were assigned based on treatment prescribed NSAIDS (group A), NSAIDS + Tramadol (group B), Opiates (group C). The following data was entered into excel sheets for statistical analysis.
RESULTS: In group A the analgesics were prescribed for an average of 6.6 days and 6.7 days in group B. 70% of the patientss in group A and 68% of patientss in group B experienced moderate pain where as 30% of the patientss in group A and 32% of the patientss in group B experienced severe pain. It was observed that 100% of patientss in group A and 95% of patients in group B experienced nausea and vomiting after 24 hours of surgery. 80% of the patientss in group A and 58% of the patientss in group B experienced mild pain where as 20% of the patientss in group A and 42% of the patientss in group B experienced discomfort pain after 72 hours of surgery.
CONCLUSION: From the study we concluded that NSAID is the drug of choice in the treatment of Post-Operative Laparoscopic Cholecystectomy. The duration of treatment is less and they showed better response when compared to other treatment options. Tramadol with NSAID can be prescribed to patients when they do not respond to NSAID’s alone.